Ingelman-Sundberg M - Search Results

1

Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles.

Bogni A, Monshouwer M, Moscone A, Hidestrand M, Ingelman-Sundberg M, Hartung T, Coecke S. Bogni A, et al. Toxicol In Vitro. 2005 Aug;19(5):621-9. doi: 10.1016/j.tiv.2005.04.001. Toxicol In Vitro. 2005. PMID: 15893449

2

A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function.

Oscarson M, Hidestrand M, Johansson I, Ingelman-Sundberg M. Oscarson M, et al. Mol Pharmacol. 1997 Dec;52(6):1034-40. doi: 10.1124/mol.52.6.1034. Mol Pharmacol. 1997. PMID: 9415713

3

Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides.

Bylund J, Hidestrand M, Ingelman-Sundberg M, Oliw EH. Bylund J, et al. J Biol Chem. 2000 Jul 21;275(29):21844-9. doi: 10.1074/jbc.M001712200. J Biol Chem. 2000. PMID: 10791960 Free article.

4

Characterization and functional analysis of two common human cytochrome P450 1B1 variants.

McLellan RA, Oscarson M, Hidestrand M, Leidvik B, Jonsson E, Otter C, Ingelman-Sundberg M. McLellan RA, et al. Arch Biochem Biophys. 2000 Jun 1;378(1):175-81. doi: 10.1006/abbi.2000.1808. Arch Biochem Biophys. 2000. PMID: 10871058

5

Role of CYP2C9 polymorphism in losartan oxidation.

Yasar U, Tybring G, Hidestrand M, Oscarson M, Ingelman-Sundberg M, Dahl ML, Eliasson E. Yasar U, et al. Drug Metab Dispos. 2001 Jul;29(7):1051-6. Drug Metab Dispos. 2001. PMID: 11408373

6

Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity.

Wennerholm A, Johansson I, Hidestrand M, Bertilsson L, Gustafsson LL, Ingelman-Sundberg M. Wennerholm A, et al. Pharmacogenetics. 2001 Jul;11(5):417-27. doi: 10.1097/00008571-200107000-00005. Pharmacogenetics. 2001. PMID: 11470994

7

The importance of residues in substrate recognition site 3 for the catalytic function of CYP2D25 (vitamin D 25-hydroxylase).

Hosseinpour F, Hidestrand M, Ingelman-Sundberg M, Wikvall K. Hosseinpour F, et al. Biochem Biophys Res Commun. 2001 Nov 9;288(4):1059-63. doi: 10.1006/bbrc.2001.5879. Biochem Biophys Res Commun. 2001. PMID: 11689019

8

Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.

Aklillu E, Oscarson M, Hidestrand M, Leidvik B, Otter C, Ingelman-Sundberg M. Aklillu E, et al. Mol Pharmacol. 2002 Mar;61(3):586-94. doi: 10.1124/mol.61.3.586. Mol Pharmacol. 2002. PMID: 11854439

9

Recent Progress in Drug Metabolism Research.

Aklillu E, Hidestrand M, Ingelman-Sundberg M, Malmebo S, Westlind A. Aklillu E, et al. Drug News Perspect. 2002 Oct;15(8):528-534. Drug News Perspect. 2002. PMID: 12677192

10

Comparative studies on the cytochrome p450-associated metabolism and interaction potential of selegiline between human liver-derived in vitro systems.

Salonen JS, Nyman L, Boobis AR, Edwards RJ, Watts P, Lake BG, Price RJ, Renwick AB, Gómez-Lechón MJ, Castell JV, Ingelman-Sundberg M, Hidestrand M, Guillouzo A, Corcos L, Goldfarb PS, Lewis DF, Taavitsainen P, Pelkonen O. Salonen JS, et al. Drug Metab Dispos. 2003 Sep;31(9):1093-102. doi: 10.1124/dmd.31.9.1093. Drug Metab Dispos. 2003. PMID: 12920164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters